The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: A cross-sectional study

American Journal of Rhinology and Allergy

Volumn 25, Issue 4, 2011, Pages 214-218

  Dheyauldeen, Sinan Ahmed ^a   Abdelnoor, Michael ^b   Bachmann Harildstad, Gregor ^c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; ENDOGLIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD TRANSFUSION; CHILD; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EPISTAXIS; FEMALE; GENDER; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; RENDU OSLER WEBER DISEASE; SCHOOL CHILD; SEX DIFFERENCE;

ACTIVIN RECEPTORS, TYPE II; ADULT; AGE OF ONSET; AGED; ANTIGENS, CD; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; EPISTAXIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; NORWAY; RECEPTORS, CELL SURFACE; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 79960472377     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2011.25.3616     Document Type: Article

References (33)

1. Shovlin CL, and Letarte M. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: Issues in clinical management and review of pathogenic mechanisms. Thorax 54:714-729, 1999. (Pubitemid 29341410)
2. Gallitelli M, Pasculli G, Fiore T, et al. Emergencies in hereditary haemorrhagic telangiectasia. QJM 99:15-22, 2006. (Pubitemid 43124967)
3. Folz BJ, Tennie J, Lippert BM, et al. Natural history and control of epistaxis in a group of German patients with Rendu-Osler-Weber disease. Rhinology 43:40-46, 2005.
4. Assar OS, Friedman CM, and White RI Jr. The natural history of epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 101: 977-980, 1991.
5. Harvey RJ, Kanagalingam J, and Lund VJ. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis. Am J Rhinol 22:182-187, 2008. (Pubitemid 351570562)
6. Shah RK, Dhingra JK, and Shapshay SM. Hereditary hemorrhagic telangiectasia: A review of 76 cases. Laryngoscope 112:767-773, 2002. (Pubitemid 34477602)
7. Sadick H, Sadick M, Gotte K, et al. Hereditary hemorrhagic telangiectasia: An update on clinical manifestations and diagnostic measures. Wien Klin Wochenschr 118:72-80, 2006.
8. Govani FS, and Shovlin CL. Hereditary haemorrhagic telangiectasia: A clinical and scientific review. Eur J Hum Genet 17:860-871, 2009.
9. Begbie ME, Wallace GM, and Shovlin CL. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): A view from the 21st century. Postgrad Med J 79:18-24, 2003. (Pubitemid 36237873)
10. Lennox PA, Hitchings AE, Lund VJ, et al. The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol 19:71-74, 2005. (Pubitemid 40444008)
11. Hitchings AE, Lennox PA, Lund VJ, et al. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol 19:75-78, 2005. (Pubitemid 40444009)
12. Sadick H, Fleischer I, Goessler U, et al. Twenty-four-hour and annual variation in onset of epistaxis in Osler disease. Chronobiol Int 24:357-364, 2007. (Pubitemid 46643418)
13. Al-Deen S, and Bachmann-Harildstad G. A grading scale for epistaxis in hereditary haemorrhagic teleangectasia. Rhinology 46:281-284, 2008.
14. Lund VJ, and Howard DJ. A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia. Am J Rhinol 13:319-322, 1999.
15. Davidson TM, Olitsky SE, and Wei JL. Hereditary hemorrhagic telangiectasia/avastin. Laryngoscope 120:432-435, 2010.
16. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91:66-67, 2000. (Pubitemid 30127562)
17. von EE, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 370:1453-1457, 2007.
18. Kirkwood BR, and Sterne JAC. Essential Medical Statistics. Malden, MA: Blackwell, 9-17, 80-176, 2003.
19. Statistics Norway. Available online at www.ssb.no/; last accessed March 2011.
20. Pasculli G, Resta F, Guastamacchia E, et al. Health-related quality of life in a rare disease: Hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease. Qual Life Res 13:1715-1723, 2004. (Pubitemid 41215251)
21. Brusgaard K, Kjeldsen AD, Poulsen L, et al. Mutations in endoglin and in activin receptor-like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia. Clin Genet 66:556-561, 2004. (Pubitemid 39562020)
22. Hoag JB, Terry P, Mitchell S, et al. An epistaxis severity score for hereditary hemorrhagic talangiectasia. Laryngoscope 120:838-843, 2010.
23. Haitjema T, Balder W, Disch FJ, et al. Epistaxis in hereditary haemorrhagic telangiectasia. Rhinology 34:176-178, 1996. (Pubitemid 26374006)
24. Reilly PJ, and Nostrant TT. Clinical manifestations of hereditary hemorrhagic telangiectasia. Am J Gastroenterol 79:363-367, 1984. (Pubitemid 14147856)
25. Plauchu H, de Chadarevian JP, Bideau A, et al. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32:291-297, 1989. (Pubitemid 19146524)
26. Stecker RH, and Lake CF. Hereditary hemorrhagic telangiectasia; review of 102 cases and presentation of an innovation to septodermoplasty. Arch Otolaryngol 82:522-526, 1965.
27. Peery WH. Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med 82:989-997, 1987.
28. McCaffrey TV, Kern EB, and Lake CF. Management of epistaxis in hereditary hemorrhagic telangiectasia. Review of 80 cases. Arch Otolaryngol 103:627-630, 1977. (Pubitemid 8217506)
29. Lesca G, Olivieri C, Burnichon N, et al. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: Data from the French-Italian HHT network. Genet Med 9:14-22, 2007. (Pubitemid 46105845)
30. Pagella F, Colombo A, Matti E, et al. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients. Am J Rhinol Allergy 23:52-58, 2009.
31. Kjeldsen AD, Moller TR, Brusgaard K, et al. Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia. J Intern Med 258:349-355, 2005. (Pubitemid 41368685)
32. Berg J, Porteous M, Reinhardt D, et al. Hereditary haemorrhagic telangiectasia: A questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet 40:585-590, 2003. (Pubitemid 37046911)
33. Sabba C, Gallitelli M, Pasculli G, et al. HHT: A rare disease with a broad spectrum of clinical aspects. Curr Pharm Des 12:1217-1220, 2006. (Pubitemid 44082127)